Tentative Scientific Program Hopecardis 2013

Tentative Scientific Program of HolisticApproach in Cardiovascular Disease 2013

FRIDAY, 07 JUNE 2013

Time Event

08.30-

08.00 Re-registration

08.00-

09.00 Meet The Expert

Ventricular Arrhytmia in Outpatient Clinics

Moderator: Nurhay A

Speaker:

M Yamin

M Munawar

Dina Oktavia (Case)

Stable Angina Pectoris: When to Consider

Interventional Therapy

Moderator: Sally A Nasution

Speaker:

Ika Prasetya Wijaya

Azhari Gani

Birry Karim (Case)

09.00-

09.30

Opening Ceremony

Welcome Speech by:

1) Chairman of Holistic Approach in Cardiovascular Diseases

2) President of Indonesian Cardiocerebrovascular Society

3) Head of Continuing Medical Education, Department of Internal Medicine

4) Head of Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia

Exhibition Opening

09.30-

10.45

Symposium I

Asymptomatic CAD: Conservative to

Intervensive Therapy

Moderator: MA Sungkar

1. Long Life Statin: Everyday Statin Vs. Once-in

Three Day Statin

Idar Mappangara

2. Long Life Antiplatelet: The Choice and The

Side Effects

Edwin Setiabudi

3. Consideration in Coronary Stenting in Chronic

Asymptomatic CAD

Refli Hasan

Discussion

Symposium II

CKD and Vascular: Need for Special Attention

Moderator: Yahya Kisyanto

1. Vascularo-Pathy in Patients with CKD:

Endothel Dysfunction

M Bonar

2. PAD Treatment in Patients with CKD

Dono Antono

3. Antiplatelet for CAD in Patients with CKD

Lugyanti

Discussion

10.45-

11.00

Coffee Break

11.00-

12.00

Plenary Lecture I

Cardiovascular Medicine: What to Expect in Near Future

12.00-

13.00 Lunch Break

13.00-

14.15

Symposium III

Acute Coronary Syndrome Update on

Pathophysiology

Moderator: Nurhay A

1. Atherosclerosis in Children

Sukman Tulus Putra

2. Hyperuricemia in Acute Coronary Syndrome

Lukman H M

3. Long Term Nitrat Vs. Pro Renata Nitrat: Which

to Choose?

Erwan Martanto

Discussion

Symposium IV

New Antiplatelet as Emerging in Patients with

ACS

Moderator: Daulat Manurung

1. Role of Platelets in ACS Patophysiology

Syafrudin Tamar

2. Ideal Antiplatelets: The Need for Newer

Antiplatelet

Budi Yuli Setianto

3. New Antiplatelet Era in ACS Treatment

Bambang Irawan

Discussion

14.15-

15.30

Symposium V

Complimentary Alternative Medicine in CAD

Moderator: Yahya Kisyanto

1. Indonesian Herbal: Recent Updates and Advance

(Focus on Cardiovascular)

Frans D Suyatna

2. L-Carnitine Supplementation: Myths and Facts

Muhadi

3. Rehabilitation Program in Post-ACS

Dedi Tedjakusuma

Discussion

Video Demonstration

Peripheral Arterial Disease (Diabetic Foot)

RSCM Experience in 10 Years

(--> Stenting Below Knee - and Its Follow Up)

dr. Dono Antono, SpPD-KKV, FINASIM, FICA

SATURDAY, 08 JUNE 2013

Time Event

07.30-

08.30 Meet The Expert

Role of Anticoagulant in ACS

Moderator: Marulam P

Speaker:

Charles L

Pendrik Tendean

Munadi (Case)

Holistic Approach in Peripheral

Vascular Disease

Moderator: Eka Ginanjar

Speaker:

Dono Antono

Murnizal Dahlan

Wawan Setyawan (Case)

Cardiac Biomarkers in ACS:

Which Ones and When?

Moderator: Muhadi

Speaker:

Marzuki

Eko Antono

Yudistira (Case)

08.30-

09.00 Plenary Lecture II

MitraClip: Update Management of Mitral Regurgitation

Moderator: Lukman H Makmun

Speaker: Yeo Khung Keong

09.00-

10.15 Symposium VI

Dyslipidemia: from Pathophysiology to Treatment

Moderator: Dono Antono

1. Dyslipidemia: Types and Treatments

Dante Saksono

2. Management of Dyslipidemia in Chronic Kidney

Disease, SHARP Study Update

Idrus Alwi

3. Rationale of Using Combination Therapies in

Dyslipidemia Management

Sally A Nasution

Discussion

Symposium VII

Metabolic Syndrome: What is New

Moderator: Lukman H M

1. Relations of Metabolic Syndrome and CAD

Focus on Slow Coronary Flow

M Diah

2. High Dose Atorvastatin Therapy in Patients

with High Risk of Metabolic Syndrome

Abdul Madjid

3. The Missing Link Between Testosteron

Deficiency Syndrome (TDS) and Metabolic

Syndrome

Em Yunir

Discussion

10.15-

10.30

Coffee Break

10.30-

11.45

Symposium VIII

Current Development in ACS Management: Focus in

Pre and Post-PCI

Moderator: Hanafi

1. Addressing Challenges in ACS with Dyslipidemia

with Potential Water Soluble Statin

Idrus Alwi

2. Translating Updated ACS Guidelines into Clinical

Practice: Role of Tecagrelor

Marulam Pangabean

Discussion

Symposium IX

RAA Axis in Hypertension

Moderator: Dasnan Ismail

1. RAAS Blockade the Foundation of

Antihipertensive Therapy

Rully A R

2. Dual Combination of Hypertensive

Management: Which and Whom?

Teguh Santoso

Discussion

11.45-

13.00

Lunch Symposium I

Leading The RE-VOLUTION: Stroke Prevention in Patients with Atrial Fibrillation: Different

Perspectives and Practical Approaches, Yo’ll be The Judge

Moderator: Marulam Pangabean

1. Navigating a Changing Landscape: What Factors Should We Consider When Choosing an Anticoagulant for

Stroke Prevention and How Can We Rely on RE-LY and RELY-ABLE

Idrus Alwi

2. Choosing The Right Path Supporting Evidence of Dabigatran Etexilate and Its Optimization for Usage in

Clinical Practice

M Yamin

Discussion

13.00-

14.00 Lunch Break

14.00-

16.00

Video Demonstration

WPW Ablation - EP Study RSCM Experience in 10 Years

M Yamin

Symposium X

Tight Blood Pressure Control and Tight

Glucose Control, Lessons from ASCOT and

ADVANCE

Moderator: Hanafi Binarto Trisnohadi

1. Diastolic Heart Failure

Ali Ghanie

2. Antihypertension in Elderly

Suhardjono

3. Glucose Control in Elderly: Sulfonilurea

Sarwono

Discussion

SUNDAY, 09 JUNE 2013

Date Event

07.30-

08.30

Meet The Expert

Endocarditis Prophylaxis in

Daily Practice

Moderator: Dasnan Ismail

Speaker:

Saharman Leman

M Halid

Robert (case)

Non-Invasive Diagnostic

Testing for Coronary

Artery Disease

Moderator: Ali Ghani

Speaker:

Sri Shujuan

Syamsu Indra

Dede Moeswir (case)

Resistent Hypertension: How

We Deal with It?

Moderator: Dharmeizar

Speaker:

Juwanto

Suhardjono

Rinaldi (Case)

08.30-

09.00

Plenary Lecture III

Echocardiography and Lung Ultrasound in Critical Ill

Moderator: Ali Ghani

Speaker: Adi Osman and Team (Win Focus Malaysia)

09.00-

10.15

Symposium XI

Congenital Heart Disease in Adult

Moderator: Sally Aman Nasution

1. Congenital Heart That Survives Into Adulthood

Mulyadi

2. Surgery in Congenital Heart Disease in Adult:

RSCM Experience

Ismail

3. ASD Closure

M Yamin

Discussion

Symposium XII

Cardiovascular Risk Factors Management

Moderator: Hans Mansjoer

1. Clinical Effect of Pitavastatin in Dyslipidemia

Management

Hanafi

2. RAAS Inhibitors in The Management of

Hypertension, ACE-Is or ARBs to Reduce

Mortality?

Ali Ghanie

3. Diabetes Management as a Risk Factor for

Cardiovascular Diseases

Slamet

Discussion

10.15-

10.30 Coffee Break

10.30-

11.45

Symposium XIII

Triglyceride and Metabolic Syndrome as

Cardiovascular Risk Factor

Moderator: Marulam P

1. Triglyceride Burden in Metabolic Syndrome

Dante Saksono

2. What Guidelines Determine on Triglyceride as

Cardiovascular Risk Factor

Idrus Alwi

3. Triglyceride Role in Atherosclerosis

Ika Prasetya

Discussion

Symposium XIV

Recent Advances in Atrial Fibrilation

Moderator: dr. Puji Rusmono Adi, SpPD-KKV

1. Atrial Fibrilation: to Coagulate or Not to

Coagulate

Taufik Indrajaya

2. Atrial Fibrilation: to Ablate or Not to

M Munawar

3. Atrial Fibrilation: LAA Closure

Teguh Santoso

Discussion

11.45-

13.00

Lunch Symposium II

Cardiovascular Outcomes as Goal of Lipid Treatment: What’s New?

Moderator: Idrus Alwi

1. New Insight on Statin Evidences: Opportunities for Improved Cardiovascular Outcomes

Teguh Santoso

2. Dyslipidemia Management: from Guidelines to Clinical Practices

Hanafi

Discussion

13.00-

14.00

Lunch Break

14.00-

16.00

Symposium XV

Diabetology in Cardiovascular Disease

Moderator: Ika PW

1. Insulin Therapy in ACS Patients

Imam Subekti

2. Cardiovascular Complication in Diabetes

Mellitus: How to Prevent

Tri Juli Edi

3. Diabetic Foot: Interventional Therapy

Eka Ginanjar

Discussion

Symposium XVI

Rheumatic Heart Disease

Moderator: JH. Awaloei

1. Rheumatic Heart Disease: Clinical Assessment

Iwang Gumiwang

2. Biomarker for Rheumatic Heart Disease

Marzuki

3. Long Term Anticoagulant in Rheumatic Heart

Disease

Ahmad Sungkar

Discussion